MTOR and Miyoshi myopathy: Therapeutic treatment with single or dual PI3K/mTOR inhibitors has previously shown to reduce the growth of established BM in preclinical studies11–13, but failed to lead to intracranial response in MM patients with established BM in a clinical trial14.